The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Molecular Differences Between Pediatric & Adult Psoriasis Plaques

Molecular Differences Between Pediatric & Adult Psoriasis Plaques

July 10, 2017 • By Marilynn Larkin

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—The pathology of pediatric psoriasis differs from that of adult psoriasis, a finding that has implications for treatment, researchers suggest.

You Might Also Like
  • The ACR Participates in Workgroup to Aid Transition of Pediatric Patients to Adult Healthcare Settings
  • Self-Driven Care Can be Difficult for Adolescents Transitioning from Pediatric to Adult Rheumatology Provider
  • Pediatric Rheumatologist Shortage Spurs Need for Adult Specialists to Treat Children with Rheumatic Conditions

“Pediatric psoriasis often differs from adult psoriasis in presentation, triggers, natural history, and response to therapy, suggesting potential differences in the pathophysiology of the disease processes,” Dr. Kelly Cordoro of the University of California, San Francisco (UCSF) and colleagues observe in the Journal of the American Academy of Dermatology, online June 14.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, most studies examining the immunology of psoriasis have focused on adult patients. For the new research, the team used flow cytometry to characterize the inflammatory cell profiles of psoriatic plaques from pediatric patients and adult psoriasis skin obtained from the UCSF General Dermatology clinics. They also studied normal skin obtained from pediatric patients undergoing plastic surgical reconstructive or excisional procedures at from which benign normal tissue margins were available and would have otherwise been discarded, and normal, healthy adult skin obtained from patients undergoing elective surgery.

Ten pediatric psoriasis patients (eight boys, mean age 12) were included in the study. Most had mild psoriasis at the time of biopsy, but moderate to severe disease was reported by all but three patients at some point during the disease course. Two had ongoing moderate and one had very severe disease at the time of enrollment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Lesional tissue from the pediatric patients had significantly increased IL-22 and significantly less elevation of IL-17 derived from CD41 and CD81 cells compared with tissues from adult psoriasis patients and pediatric controls.

Also in contrast to lesions from adults, lesional skin in pediatric patients did not have increases in regulatory T cells.

Dr. Cordoro tells Reuters Health, “This pilot study supports the notion that ‘kids are not just little adults’ when it comes to the immunopathology of psoriasis at the tissue level.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“The results provide evidence that IL-22, in addition to and to a greater extent than IL-17, may be a major player in the pathologic mechanism of psoriasis in children,” she says by email.

“The overarching goal of research like this is to start a new era in which physicians are no longer forced to adapt knowledge gained from adult studies to the management of pediatric patients,” she stresses. “Our findings get us a step closer to unraveling the immunologic signature of pediatric psoriasis, which may reveal therapeutic targets unique to children.”

Dr. Adnan Mir, a pediatric dermatologist at Children’s Health in Dallas, tells Reuters Health by email, “Psoriasis often behaves differently in children and adults, and little is known about why that is the case. For example, psoriasis in children is often triggered by Streptococcal infections, such as Strep throat.”

“Despite the differences, we often treat adult and pediatric psoriasis using similar strategies,” he says.

“Over the past two to three decades, advances in the understanding of what causes psoriasis has led to the development of more sophisticated, targeted therapies—but these have, for the most part, been focused on adult disease,” he observes.

“This is an important study that addresses differences in adult and pediatric psoriasis at a molecular level,” he says. “This improved understanding of the cellular and molecular pathways that are active in pediatric psoriasis will help us to tailor our treatments specifically to this population, and lead to the development of newer, safer therapies.”


Reference

  1. Cordoro KM, Hitraya-Low M, Taravati K, et al. Skin-infiltrating, interleukin-22-producing T cells differentiate pediatric psoriasis from adult psoriasis. J Am Acad Dermatol. 2017 Jun 14. pii: S0190-9622(17)31735-8. doi: 10.1016/j.jaad.2017.05.017. [Epub ahead of print]

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Scleroderma Tagged With: adult, Children, Pediatric, plaque, Psoriasis, skin

You Might Also Like:
  • The ACR Participates in Workgroup to Aid Transition of Pediatric Patients to Adult Healthcare Settings
  • Self-Driven Care Can be Difficult for Adolescents Transitioning from Pediatric to Adult Rheumatology Provider
  • Pediatric Rheumatologist Shortage Spurs Need for Adult Specialists to Treat Children with Rheumatic Conditions
  • Wise Transitions: Improving Pediatric–Adult Care

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.